These compounds on reversing MDR to chemotherapeutic agents were evaluated using human oral epidermoid carcinoma KB, human leukemia K562 cells and their drug resistant counterparts KBV200 and K562/ADR cells with P-gp overexpression. The gene discussed is PGP; the disease is leukemia.